Adam Goulburn
InvestorManaging Partner at Dimension Capital
New York, New York
Writes $1M – $10M checks · typically $2M
About
Adam Goulburn, a PhD neuroscientist-turned-investor who founded or incubated Cajal Neuroscience and Kallyope, takes operational roles to build technically ambitious, biology-digitization ventures (microbiome, brain-computer interfaces, patient-accelerated drug development).
Invests in
AI & Machine LearningBiotechData & InfrastructureRoboticsSaaS
Experience
- DimensionCo-Foundercurrent2022 — presentNew York
- Lux CapitalVenture Partner2022
- Lux CapitalPartner2015 — 2022
- Lux CapitalPrincipal2014 — 2015New York City Metropolitan Area
- Lux CapitalSenior Associate2012 — 2014New York City Metropolitan Area
- Lux CapitalAssociate2011 — 2012New York
- VNV Bio (now Aera Therapeutics)Founding CEO2018 — 2021New York, United States
- KallyopeFounding CEO2014 — 2015New York
- Weill Cornell Medical CollegePost-Doctoral Associate2010 — 2011New York
Education
- Monash UniversityPhD, Stem Cell Research2006 — 2010
- UNSWBachelor of Commerce / Bachelor of Science, International Business2001 — 2005
Skills & more
From Adam's professional profile.
Same school
Also attended Monash University96
+ 90 more
Also attended UNSW190
+ 184 more
Shared employers
Also worked at Lux Capital49
+ 43 more
Also worked at Kallyope5
Also worked at Weill Cornell Medical College25
+ 19 more
Deals · 5
Variant BioBoard seat
via Dimension Capital · filed Oct 2019 · $31.5M raise
Drone Racing LeagueBoard seat
via Dimension Capital · filed Jun 2019 · $50M raise
3ScanBoard seat
via Dimension Capital · filed Jul 2016 · $14M raise
AuthoreaBoard seat
via Dimension Capital · filed Jan 2016 · $1.5M raise
CareGuardianBoard seat
via Dimension Capital · filed Jan 2016 · $30.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Dimension Capital
Network10
Investors connected to Adam in public investor directories — a warm-intro map.



:format(webp)/f/174198/3860x2650/d857c55b6f/steel-blue-clarissa.png)































